. 2007 Mar;96(8).
doi: 10.1038/sj.bjc.6603673.

Interpretation of microarray data in cancer

S Michiels 1 S Koscielny  C Hill  
  • PMID: 17342085
  •     29 References
  •     27 citations


Microarray studies aim at identifying homogeneous subtypes of cancer patients, searching for differentially expressed genes in tumours with different characteristics, or predicting the prognosis of patients. Using breast cancer as an example, we discuss the hypotheses underlying these studies, their power, and the validity and the clinical usefulness of the findings.

Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data.
R Simon.
Br J Cancer, 2003 Oct 30; 89(9). PMID: 14583755    Free PMC article.
Microarrays and clinical investigations.
Edison T Liu, Krishna R Karuturi.
N Engl J Med, 2004 Apr 16; 350(16). PMID: 15084689
Microarray data analysis: from disarray to consolidation and consensus.
David B Allison, Xiangqin Cui, Grier P Page, Mahyar Sabripour.
Nat Rev Genet, 2005 Dec 22; 7(1). PMID: 16369572
Highly Cited. Review.
Optimal gene expression analysis by microarrays.
Lance D Miller, Philip M Long, +3 authors, Edison T Liu.
Cancer Cell, 2002 Nov 27; 2(5). PMID: 12450790
REporting recommendations for tumour MARKer prognostic studies (REMARK).
L M McShane, D G Altman, +4 authors, Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.
Br J Cancer, 2005 Aug 18; 93(4). PMID: 16106245    Free PMC article.
Highly Cited.
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.
Marc Buyse, Sherene Loi, +18 authors, TRANSBIG Consortium.
J Natl Cancer Inst, 2006 Sep 07; 98(17). PMID: 16954471
Highly Cited.
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, +15 authors, D Botstein.
Nature, 2000 Aug 30; 406(6797). PMID: 10963602
Highly Cited.
Gene expression profiling predicts clinical outcome of breast cancer.
Laura J van 't Veer, Hongyue Dai, +13 authors, Stephen H Friend.
Nature, 2002 Feb 02; 415(6871). PMID: 11823860
Highly Cited.
Individual response to treatment: is it a valid assumption?
Stephen Senn.
BMJ, 2004 Oct 23; 329(7472). PMID: 15499115    Free PMC article.
Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis?
Daniela Dunkler, Stefan Michiels, Michael Schemper.
Eur J Cancer, 2007 Jan 30; 43(4). PMID: 17257824
Why most published research findings are false.
John P A Ioannidis.
PLoS Med, 2005 Aug 03; 2(8). PMID: 16060722    Free PMC article.
Highly Cited.
Concordance among gene-expression-based predictors for breast cancer.
Cheng Fan, Daniel S Oh, +5 authors, Charles M Perou.
N Engl J Med, 2006 Aug 11; 355(6). PMID: 16899776
Highly Cited.
Prediction of cancer outcome with microarrays: a multiple random validation strategy.
Stefan Michiels, Serge Koscielny, Catherine Hill.
Lancet, 2005 Feb 12; 365(9458). PMID: 15705458
Highly Cited.
A progression puzzle.
René Bernards, Robert A Weinberg.
Nature, 2002 Aug 23; 418(6900). PMID: 12192390
Highly Cited.
Validation of microarray data by quantitative reverse-transcriptase polymerase chain reaction.
Serge Koscielny, Stefan Michiels, Valérie Boige, Catherine Hill.
J Clin Oncol, 2005 Dec 20; 23(36). PMID: 16361648
"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers.
Patrik Edén, Cecilia Ritz, +2 authors, Carsten Peterson.
Eur J Cancer, 2004 Aug 04; 40(12). PMID: 15288284
Gene expression profiling for individualized breast cancer chemotherapy: success or not?
John P A Ioannidis.
Nat Clin Pract Oncol, 2006 Oct 05; 3(10). PMID: 17019431
Rules of evidence for cancer molecular-marker discovery and validation.
David F Ransohoff.
Nat Rev Cancer, 2004 Apr 02; 4(4). PMID: 15057290
Highly Cited. Review.
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.
Yixin Wang, Jan G M Klijn, +11 authors, John A Foekens.
Lancet, 2005 Feb 22; 365(9460). PMID: 15721472
Highly Cited.
Roadmap for developing and validating therapeutically relevant genomic classifiers.
Richard Simon.
J Clin Oncol, 2005 Sep 08; 23(29). PMID: 16145063
Highly Cited. Review.
Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study.
E Espinosa, J A Fresno Vara, +9 authors, M González Barón.
J Clin Oncol, 2005 Sep 01; 23(29). PMID: 16129846
Microarrays and molecular research: noise discovery?
John P A Ioannidis.
Lancet, 2005 Feb 12; 365(9458). PMID: 15705441
What do we mean by validating a prognostic model?
D G Altman, P Royston.
Stat Med, 2000 Mar 01; 19(4). PMID: 10694730
Highly Cited.
False discovery rate, sensitivity and sample size for microarray studies.
Yudi Pawitan, Stefan Michiels, +2 authors, Alexander Ploner.
Bioinformatics, 2005 Apr 21; 21(13). PMID: 15840707
Highly Cited.
Bias as a threat to the validity of cancer molecular-marker research.
David F Ransohoff.
Nat Rev Cancer, 2005 Feb 03; 5(2). PMID: 15685197
Highly Cited. Review.
Road map to metastasis.
Laura J Van't Veer, Britta Weigelt.
Nat Med, 2003 Aug 02; 9(8). PMID: 12894162
Is cross-validation valid for small-sample microarray classification?
Ulisses M Braga-Neto, Edward R Dougherty.
Bioinformatics, 2004 Feb 13; 20(3). PMID: 14960464
Highly Cited.
New molecularly targeted therapies for lung cancer.
Sophie Sun, Joan H Schiller, Monica Spinola, John D Minna.
J Clin Invest, 2007 Oct 03; 117(10). PMID: 17909619    Free PMC article.
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.
Bas J Wouters, Bob Löwenberg, Ruud Delwel.
Blood, 2008 Aug 16; 113(2). PMID: 18703705    Free PMC article.
Combining a molecular profile with a clinical and pathological profile: biostatistical considerations.
Richard J Sylvester.
Scand J Urol Nephrol Suppl, 2008 Dec 05; (218). PMID: 18815933    Free PMC article.
[Genome-wide expression profiling as a clinical tool: are we there yet?].
F C Geyer, T Decker, J S Reis-Filho.
Pathologe, 2009 Feb 17; 30(2). PMID: 19219435
Biological convergence of cancer signatures.
Xavier Solé, Núria Bonifaci, +11 authors, Miguel Angel Pujana.
PLoS One, 2009 Feb 21; 4(2). PMID: 19229342    Free PMC article.
Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer.
M Loddo, S R Kingsbury, +10 authors, G H Williams.
Br J Cancer, 2009 Feb 26; 100(6). PMID: 19240714    Free PMC article.
Are RAS mutations predictive markers of resistance to standard chemotherapy?
Yohann Loriot, Pierre Mordant, +2 authors, Jean-Charles Soria.
Nat Rev Clin Oncol, 2009 Jul 15; 6(9). PMID: 19597509
Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinoma.
F Végran, R Boidot, +7 authors, S Lizard-Nacol.
Br J Cancer, 2009 Sep 17; 101(8). PMID: 19755993    Free PMC article.
Microsatellite instability in colorectal cancer-the stable evidence.
Eduardo Vilar, Stephen B Gruber.
Nat Rev Clin Oncol, 2010 Feb 10; 7(3). PMID: 20142816    Free PMC article.
Highly Cited. Review.
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.
Sabine Tejpar, Monica Bertagnolli, +18 authors, Arnaud Roth.
Oncologist, 2010 Mar 31; 15(4). PMID: 20350999    Free PMC article.
Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis.
Matthieu Peyre, Frédéric Commo, +11 authors, Jacques Grill.
PLoS One, 2010 Oct 05; 5(9). PMID: 20885975    Free PMC article.
Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry.
Britta Weigelt, Jorge S Reis-Filho.
Breast Cancer Res, 2011 Jan 05; 12 Suppl 4. PMID: 21172089    Free PMC article.
Multidimensionality of microarrays: statistical challenges and (im)possible solutions.
Stefan Michiels, Andrew Kramar, Serge Koscielny.
Mol Oncol, 2011 Feb 26; 5(2). PMID: 21349780    Free PMC article.
Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement.
Alan Mackay, Britta Weigelt, +7 authors, Jorge S Reis-Filho.
J Natl Cancer Inst, 2011 Mar 23; 103(8). PMID: 21421860    Free PMC article.
Quantifying stability in gene list ranking across microarray derived clinical biomarkers.
Sebastian Schneckener, Nilou S Arden, Andreas Schuppert.
BMC Med Genomics, 2011 Oct 15; 4. PMID: 21996057    Free PMC article.
Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.
Ke-Feng Lei, Bing-Ya Liu, +4 authors, Zheng-Gang Zhu.
Exp Ther Med, 2012 Sep 13; 3(1). PMID: 22969854    Free PMC article.
Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.
H A Azim, S Michiels, +9 authors, C Swanton.
Ann Oncol, 2013 Jan 23; 24(3). PMID: 23337633    Free PMC article.
The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes.
George P Stathopoulos, Nikolaos A Malamos, +6 authors, Photini Antoniou.
Anticancer Drugs, 2014 Jun 21; 25(8). PMID: 24949917    Free PMC article.
Prognostic value of a 92-probe signature in breast cancer.
Salima Akter, Tae Gyu Choi, +17 authors, Sung Soo Kim.
Oncotarget, 2015 Apr 18; 6(17). PMID: 25883221    Free PMC article.
False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review.
Anastasia Chalkidou, Michael J O'Doherty, Paul K Marsden.
PLoS One, 2015 May 06; 10(5). PMID: 25938522    Free PMC article.
Highly Cited. Systematic Review.
Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
Ren-qiang Huang, Dong-liang Shi, +2 authors, Yi-cheng Lu.
J Neurooncol, 2016 Jan 05; 127(2). PMID: 26725095
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice.
S Michiels, N Ternès, F Rotolo.
Ann Oncol, 2016 Sep 17; 27(12). PMID: 27634691    Free PMC article.
Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.
Vida Pourteimoor, Samira Mohammadi-Yeganeh, Mahdi Paryan.
Tumour Biol, 2016 Sep 22; 37(11). PMID: 27651157
Identification of biomarker-by-treatment interactions in randomized clinical trials with survival outcomes and high-dimensional spaces.
Nils Ternès, Federico Rotolo, Georg Heinze, Stefan Michiels.
Biom J, 2016 Nov 20; 59(4). PMID: 27862181    Free PMC article.
Characteristics and Validation Techniques for PCA-Based Gene-Expression Signatures.
Anders E Berglund, Eric A Welsh, Steven A Eschrich.
Int J Genomics, 2017 Mar 08; 2017. PMID: 28265563    Free PMC article.
Identification of a gene signature associated with radiotherapy and prognosis in gliomas.
Shu Li, Juanhong Shi, +11 authors, Shiting Li.
Oncotarget, 2017 Nov 29; 8(51). PMID: 29179492    Free PMC article.
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study.
Carmen D Herling, Kevin R Coombes, +14 authors, Lynne V Abruzzo.
Lancet Oncol, 2019 Oct 05; 20(11). PMID: 31582354    Free PMC article.